Beam Therapeutics Ended 2Q 2026 With $1.2 B in Cash, Cash Equivalents and Marketable Securities >BEAM

Dow Jones2026/08/04 11:00

By:Dow Jones

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

NASDAQ TRADE HALT <LHSW.O> VOLATILITY TRADING PAUSE AT 01:49 PM

Reuters•2026/09/08 17:49

Boston Scientific Flags Guidance Miss Amid 'Material Impact' From Cybersecurity Incident; Shares Fall

MT newswire•2026/09/08 17:45

NASDAQ TRADE HALT <LHSW.O> VOLATILITY TRADING PAUSE AT 01:38 PM

Reuters•2026/09/08 17:38

Ethereum Hegotá Upgrade Puts 2 EIPs at Center of 62-Proposal Crypto Shakeup

Crypto Ninjas•2026/09/08 17:36